Making Intracellular Biologics A Reality

Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases

Our Mission

Our mission is to treat devastating diseases with intracellular biologics. Our novel approach addresses challenges associated with the design and development of biologics for the intracellular space and allows us to engage targets previously considered inaccessible and undruggable.

Learn More

Our Pipeline

Using our Endosomal Escape Vehicle™ platform, we are creating a pipeline of oligonucleotide therapies to treat neuromuscular diseases including Duchenne muscular dystrophy. Our other intracellular biologics programs include intracellular antibodies, peptides, enzymes and proteins.

Learn More

Life at Entrada

Join our team if you share our values, our devotion to patients and our passion for science